CLINICAL_TRIALS
trial_result
· 2021-05-19
Clinical Trial Update: Safety and Efficacy Assessments of Osalmid in Multiple Myeloma [Phase 1, Phase 2]
Summary
Early-phase clinical trial update evaluating safety and efficacy of Osalmid in patients with Multiple Myeloma (Phase 1/2).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shanghai 10th People's Hospital | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: UNKNOWN